Download PDF
Semin Respir Crit Care Med 2009; 30(2): 136-145
DOI: 10.1055/s-0029-1202932
© Thieme Medical Publishers

The European Vision of Community-Acquired Pneumonia

Mark Woodhead1 , 2
  • 1Department of General and Respiratory Medicine, Manchester Royal Infirmary, Manchester, United Kingdom
  • 2University of Manchester, Manchester, United Kingdom
Further Information

Publication History

Publication Date:
18 March 2009 (online)

    Permissions and Reprints

ABSTRACT

Community-acquired pneumonia is common throughout the 53 European countries. Despite differences in population structure and habits there are many similarities between countries, including overall frequency and distribution of major causative pathogens. There are, however, also differences between countries, particularly in the frequency of bacterial antibiotic resistance and to a lesser extent how the condition is managed. Having said this there are many gaps in our knowledge with little or no data available from some countries, especially those in the eastern Europe. It is hoped that future years will see these gaps filled through continuing research.

KEYWORDS

Community-acquired pneumonia - Europe - pathogens - antibiotic resistance - management

REFERENCES

  • 1 Jokinen C, Heiskanen L, Juvonen H et al.. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland.  Am J Epidemiol. 1993;  137 977-988
    PubMedGoogle Scholar
  • 2 Woodhead M, Blasi F, Ewig S et al.. Guidelines for the management of adult lower respiratory tract infections.  Eur Respir J. 2005;  26 1138-1180
    CrossrefPubMedGoogle Scholar
  • 3 Laurichesse H, Robin F, Gerbaud L et al.. Empirical therapy for nonhospitalized patients with community-acquired pneumonia. Study Group of General Practitioners.  Eur Respir J. 1998;  11 73-78
    CrossrefPubMedGoogle Scholar
  • 4 Almirall J, Bolibar I, Serra-Prat M et al.. New evidence of risk factors for community-acquired pneumonia: a population-based study.  Eur Respir J. 2008;  31 1274-1284
    CrossrefPubMedGoogle Scholar
  • 5 Viegi G, Pistelli R, Cazzola M et al.. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.  Respir Med. 2006;  100 46-55
    CrossrefPubMedGoogle Scholar
  • 6 Woodhead M A, Macfarlane J T, McCracken J S, Rose D H, Finch R G. Prospective study of the aetiology and outcome of pneumonia in the community.  Lancet. 1987;  1 671-674
    PubMedGoogle Scholar
  • 7 Schnoor M, Hedicke J, Dalhoff K, Raspe H, Schafer T. Approaches to estimate the population-based incidence of community acquired pneumonia.  J Infect. 2007;  55 233-239
    CrossrefPubMedGoogle Scholar
  • 8 Woodhead M. Epidemiology of adult hospitalized community-acquired pneumonia. In: Torres A, Menendez R Community-Acquired Pneumonia: Strategies for Management. 1st ed. Chichester; John Wiley & sons 2008: 5-19
    Google Scholar
  • 9 Fine M J, Auble T E, Yealy D M et al.. A prediction rule to identify low-risk patients with community-acquired pneumonia.  N Engl J Med. 1997;  336 243-250
    CrossrefPubMedGoogle Scholar
  • 10 Gutierrez F, Masia M, Rodriguez J C et al.. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain.  Clin Microbiol Infect. 2005;  11 788-800
    CrossrefPubMedGoogle Scholar
  • 11 Ortega L, Sierra M, Dominguez J et al.. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia.  Scand J Infect Dis. 2005;  37 657-663
    CrossrefPubMedGoogle Scholar
  • 12 Espana P P, Capelastegui A, Quintana J M et al.. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.  Eur Respir J. 2003;  21 695-701
    CrossrefPubMedGoogle Scholar
  • 13 Lim W S, van der Eerden M M, Laing R et al.. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.  Thorax. 2003;  58 377-382
    CrossrefPubMedGoogle Scholar
  • 14 Logroscino C D, Penza O, Locicero S et al.. Community-acquired pneumonia in adults: a multicentric observational AIPO study.  Monaldi Arch Chest Dis. 1999;  54 11-17
    PubMedGoogle Scholar
  • 15 van der Eerden M M, de Graaff C S, Bronsveld W, Jansen H M, Boersma W G. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia.  Respir Med. 2004;  98 872-878
    CrossrefPubMedGoogle Scholar
  • 16 Roson B, Carratala J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.  Clin Infect Dis. 2001;  33 158-165
    CrossrefPubMedGoogle Scholar
  • 17 Buising K L, Thursky K A, Black J F et al.. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia.  Thorax. 2006;  61 419-424
    CrossrefPubMedGoogle Scholar
  • 18 Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients.  Scand J Infect Dis. 1987;  19 491-501
    PubMedGoogle Scholar
  • 19 Lorente M L, Falguera M, Nogues A, Gonzalez A R, Merino M T, Caballero M R. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study.  Thorax. 2000;  55 133-137
    CrossrefPubMedGoogle Scholar
  • 20 Menendez R, Cordoba J, de La C P et al.. Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.  Am J Respir Crit Care Med. 1999;  159 1868-1873
    PubMedGoogle Scholar
  • 21 Ruiz M, Ewig S, Marcos M A et al.. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.  Am J Respir Crit Care Med. 1999;  160 397-405
    PubMedGoogle Scholar
  • 22 Ortqvist A, Hedlund J, Grillner L et al.. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization.  Eur Respir J. 1990;  3 1105-1113
    PubMedGoogle Scholar
  • 23 Gomez J, Banos V, Ruiz Gomez J et al.. Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.  Eur J Clin Microbiol Infect Dis. 1996;  15 556-560
    CrossrefPubMedGoogle Scholar
  • 24 Macfarlane J T, Finch R G, Ward M J, Macrae A D. Hospital study of adult community-acquired pneumonia.  Lancet. 1982;  2 255-258
    PubMedGoogle Scholar
  • 25 Lévy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. Importance of initial non-invasive bacteriologic and radiographic investigations.  Chest. 1988;  93 43-48
    CrossrefPubMedGoogle Scholar
  • 26 Berntsson E, Lagergard T, Strannegard O, Trollfors B. Etiology of community-acquired pneumonia in outpatients.  Eur J Clin Microbiol. 1986;  5 446-447
    CrossrefPubMedGoogle Scholar
  • 27 Blanquer J, Blanquer R, Borras R et al.. Aetiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study.  Thorax. 1991;  46 508-551
    CrossrefPubMedGoogle Scholar
  • 28 Almirall J, Morato I, Riera F et al.. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study.  Eur Respir J. 1993;  6 14-18
    PubMedGoogle Scholar
  • 29 Melbye H, Straume B, Aasebo U, Dale K. Diagnosis of pneumonia in adults in general practice.  Scand J Prim Health Care. 1992;  10 226-233
    CrossrefPubMedGoogle Scholar
  • 30 Michetti G, Pugliese C, Bamberga M et al.. Community-acquired pneumonia: is there difference in etiology between hospitalized and outpatients.  Minerva Med. 1995;  86 341-351
    PubMedGoogle Scholar
  • 31 Lagerstrom F, Bader M, Foldevi M, Fredlund H, Nordin-Olsson I, Holmberg H. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden.  Clin Microbiol Infect. 2003;  9 645-652
    CrossrefPubMedGoogle Scholar
  • 32 White R J, Blainey A D, Harrison K J, Clarke S KR. Causes of pneumonia presenting to a district general hospital.  Thorax. 1981;  36 566-570
    CrossrefPubMedGoogle Scholar
  • 33 McNabb W R, Shanson D C, Williams T DM, Lant A F. Adult community-acquired pneumonia in central London.  J R Soc Med. 1984;  77 550-555
    PubMedGoogle Scholar
  • 34 British Thoracic Society . Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome.  Q J Med. 1987;  62 195-220
    PubMedGoogle Scholar
  • 35 Lim W S, Macfarlane J T, Boswell T C et al.. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.  Thorax. 2001;  56 296-301
    CrossrefPubMedGoogle Scholar
  • 36 Howard L S, Sillis M, Pasteur M C, Kamath A V, Harrison B D. Microbiological profile of community-acquired pneumonia in adults over the last 20 years.  J Infect. 2005;  50 107-113
    CrossrefPubMedGoogle Scholar
  • 37 Berntsson E, Blomberg J, Lagergard T, Trollfors B. Etiology of community-acquired pneumonia in patients requiring hospitalization.  Eur J Clin Microbiol. 1985;  4 268-272
    CrossrefPubMedGoogle Scholar
  • 38 Burman L A, Trollfors B, Andersson B et al.. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens.  J Infect Dis. 1991;  163 1087-1093
    PubMedGoogle Scholar
  • 39 Ostergaard L, Andersen P L. Etiology of community-acquired pneumonia: evaluation by transtracheal aspiration, blood culture or serology.  Chest. 1993;  104 1400-1407
    PubMedGoogle Scholar
  • 40 Ausina V, Coll P, Sambeat M et al.. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain.  Eur J Clin Microbiol Infect Dis. 1988;  7 342-347
    CrossrefPubMedGoogle Scholar
  • 41 Falco V, Fernandez de Sevilla T, Alegre J, Ferrer A, Vazquez J MM. Legionella pneumophila: a cause of severe community-acquired pneumonia.  Chest. 1991;  100 1007-1011
    PubMedGoogle Scholar
  • 42 Pareja A, Bernal C, Leyva A, Piedrola G, Maroto M C. Etiologic study of patients with community-acquired pneumonia.  Chest. 1992;  101 1207-1210
    CrossrefPubMedGoogle Scholar
  • 43 Sopena N, Sabria M, Pedro-Botet M L et al.. Prospective study of community-acquired pneumonia of bacterial etiology in adults.  Eur J Clin Microbiol Infect Dis. 1999;  18 852-858
    CrossrefPubMedGoogle Scholar
  • 44 Arancibia F, Bauer T T, Ewig S et al.. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis.  Arch Intern Med. 2002;  162 1849-1858
    CrossrefPubMedGoogle Scholar
  • 45 Marcos M A, Jimenez de Anta M T, de la Bellacasa J P et al.. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.  Eur Respir J. 2003;  21 209-214
    CrossrefPubMedGoogle Scholar
  • 46 Fernández Alvarez R, Suárez Toste I, Rubinos Cuadrado G et al.. Community-acquired pneumonia: aetiologic changes in a limited geographic area: an 11-year prospective study.  Eur J Clin Microbiol Infect Dis. 2007;  26 495-499
    CrossrefPubMedGoogle Scholar
  • 47 Blasi F, Cosentini R, Raccanelli R et al.. Emerging pathogens of community-acquired pneumonia: a two-year prospective study.  J Chemother. 1995;  7(Suppl 4) 115-116
    PubMedGoogle Scholar
  • 48 Aubertin J, Dabis F, Fleurette J et al.. Prevalence of legionellosis among adults: a study of community-acquired pneumonia in France.  Infection. 1987;  15 328-331
    CrossrefPubMedGoogle Scholar
  • 49 Woodhead M A, Macfarlane J T, Rodgers F G, Laverick A, Pilkington R, Macrae A D. Aetiology and outcome of severe community-acquired pneumonia.  J Infect. 1985;  10 204-210
    CrossrefPubMedGoogle Scholar
  • 50 Alkhayer M, Jenkins P F, Harrison B DW. The outcome of community-acquired pneumonia treated on the intensive care unit.  Respir Med. 1990;  84 13-16
    CrossrefPubMedGoogle Scholar
  • 51 British Thoracic Society Research committee . The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit.  Respir Med. 1992;  86 7-13
    CrossrefPubMedGoogle Scholar
  • 52 Hirani N A, Macfarlane J T. Impact of management guidelines on the outcome of severe community acquired pneumonia.  Thorax. 1997;  52 17-21
    PubMedGoogle Scholar
  • 53 Ortqvist A, Sterner G, Nilsson J A. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.  Scand J Infect Dis. 1985;  17 377-386
    PubMedGoogle Scholar
  • 54 Sorensen J, Forsberg P, Hakanson E et al.. A new diagnostic approach to the patient with severe pneumonia.  Scand J Infect Dis. 1989;  21 33-41
    PubMedGoogle Scholar
  • 55 Pachon J, Prados M D, Capote F, Cuello J A, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis and treatment.  Am Rev Respir Dis. 1990;  142 369-373
    CrossrefPubMedGoogle Scholar
  • 56 Torres A, Serra-batlles J, Ferrer A et al.. Severe community-acquired pneumonia: epidemiology and prognostic factors.  Am Rev Respir Dis. 1991;  144 312-318
    CrossrefPubMedGoogle Scholar
  • 57 Rello J, Quintana E, Ausina V, Net A, Prats G. A three year study of severe community-acquired pneumonia with emphasis on outcome.  Chest. 1993;  103 232-235
    PubMedGoogle Scholar
  • 58 Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit.  Chest. 1995;  107 511-516
    CrossrefPubMedGoogle Scholar
  • 59 Olaechea P M, Quintana J M, Gallardo M S, Insausti J, Maravi E, Alvarez B. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.  Intensive Care Med. 1996;  22 1294-1300
    PubMedGoogle Scholar
  • 60 Leroy O, Santre C, Beuscart C et al.. A five year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.  Intensive Care Med. 1995;  21 24-31
    CrossrefPubMedGoogle Scholar
  • 61 Moine P, Vercken J-P, Chevret S, Chastang C, Gajdos P. French study group for community-acquired pneumonia in the intensive care unit: severe community-acquired pneumonia: etiology, epidemiology and prognosis factors.  Chest. 1994;  105 1487-1495
    CrossrefPubMedGoogle Scholar
  • 62 Wellinghausen N, Straube E, Freidank H, von Baum H, Marre R, Essig A. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia.  Int J Med Microbiol. 2006;  296 485-491
    CrossrefPubMedGoogle Scholar
  • 63 Socan M, Marinic-Fiser N, Kraigher A, Kotnik A, Logar M. Microbial aetiology of community-acquired pneumonia in hospitalised patients.  Eur J Clin Microbiol Infect Dis. 1999;  18 777-782
    CrossrefPubMedGoogle Scholar
  • 64 Leesik H, Ani U, Juhani A, Altraja A. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.  Medicina (Kaunas). 2006;  42 384-394
    PubMedGoogle Scholar
  • 65 EARSS Management Team .EARSS Annual Report 2006. Bilthoven, the Netherlands; EARSS 2007
    Google Scholar
  • 66 Riedel S, Beekmann S E, Heilmann K P et al.. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae .  Eur J Clin Microbiol Infect Dis. 2007;  26 485-490
    CrossrefPubMedGoogle Scholar
  • 67 Goossens H, Ferech M, Vander S R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.  Lancet. 2005;  365 579-587
    PubMedGoogle Scholar
  • 68 Huchon G J, Gialdroni Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.  Eur Respir J. 1996;  9 1590-1595
    CrossrefPubMedGoogle Scholar
  • 69 Kohlhammer Y, Raspe H, Marre R, Suttorp N, Welte T, Schafer T. Antibiotic treatment of community acquired pneumonia varies widely across Germany.  J Infect. 2007;  54 446-453
    CrossrefPubMedGoogle Scholar
  • 70 Capelastegui A, Espana P P, Quintana J M et al.. Management of community-acquired pneumonia and secular trends at different hospitals.  Respir Med. 2005;  99 268-278
    CrossrefPubMedGoogle Scholar
  • 71 Hedlund J, Ortqvist A, Ahlqvist T et al.. Management of patients with community-acquired pneumonia treated in hospital in Sweden.  Scand J Infect Dis. 2002;  34 887-892
    CrossrefPubMedGoogle Scholar
  • 72 Schouten J A, Prins J M, Bonten M et al.. Optimizing the antibiotics policy in the Netherlands, VIII: Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia.  Ned Tijdschr Geneeskd. 2005;  149 2495-2500
    PubMedGoogle Scholar
  • 73 Alfageme I, Aspa J, Bello S et al.. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).  Arch Bronconeumol. 2005;  41 272-289
    CrossrefPubMedGoogle Scholar
  • 74 Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults.  Scand J Infect Dis. 2005;  37 791-805
    CrossrefPubMedGoogle Scholar
  • 75 BTS Pneumonia Guidelines Committee .BTS guidelines for the management of community-acquired pneumonia in adults—2004 update. Available at: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf 2004
    Google Scholar
  • 76 Hoffken G, Lorenz J, Kern W et al.. S3-guideline on ambulant acquired pneumonia and deep airway infections.  Pneumologie. 2005;  59 612-664
    PubMedGoogle Scholar

Mark WoodheadD.M. 

Department of Respiratory Medicine, Manchester Royal Infirmary

Oxford Road, Manchester M13 9WL, UK

Email: mark.woodhead@cmft.nhs.uk